Atika Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Sell |
16,400
-18,800
| -53% | -$3.24M | 0.28% | 50 |
|
|
2025
Q1 | $5.49M | Buy |
+35,200
| New | +$5.49M | 0.77% | 38 |
|
|
2024
Q4 | – | Sell |
-43,000
| Closed | -$6.42M | – | 79 |
|
|
2024
Q3 | $6.42M | Buy |
+43,000
| New | +$6.42M | 0.66% | 47 |
|
|
2024
Q2 | – | Sell |
-48,500
| Closed | -$7.33M | – | 77 |
|
|
2024
Q1 | $7.33M | Buy |
+48,500
| New | +$7.33M | 0.72% | 48 |
|
|
2020
Q1 | – | Sell |
-52,000
| Closed | -$7.23M | – | 75 |
|
|
2019
Q4 | $7.23M | Buy |
52,000
+27,000
| +108% | +$3.76M | 1.4% | 30 |
|
|
2019
Q3 | $2.41M | Sell |
25,000
-16,000
| -39% | -$1.54M | 0.51% | 51 |
|
|
2019
Q2 | $4.72M | Sell |
41,000
-5,000
| -11% | -$576K | 0.93% | 44 |
|
|
2019
Q1 | $5.41M | Buy |
+46,000
| New | +$5.41M | 1.1% | 32 |
|
|
2018
Q3 | – | Sell |
-15,700
| Closed | -$1.04M | – | 74 |
|
|
2018
Q2 | $1.04M | Buy |
+15,700
| New | +$1.04M | 0.2% | 64 |
|